Ramon Handerson Gomes Teles,1 Herick Fernando Moralles,2 Márcia Regina Cominetti1 1Department of Gerontology, 2Department of Production Engineering, Federal University of São Carlos, São Carlos, SP, Brazil Abstract: Nanotechnology has emerged as a promising tool in the clinic to combat several difficult-to-manage diseases, such as cancer, which is the second leading cause of death worldwide. Chemotherapeutic drugs present several limitations such as undesired side effects, low specificity, resistance, and high relapse rates. Triple negative breast cancer (TNBC) is caused by cells that lack specific receptors in their membrane, such as estrogen (ER+) and progesterone (PR+) receptors, or by cells that do not express the a...
Breast cancer is the second leading cause of cancer-related death of women in the United States, and...
Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has been foun...
BackgroundLiver cancer (LC) is one of the most common malignancies. Currently, nanotechnology has ma...
This study presents a new way to investigate comprehensive trends in cancer nanotechnology research ...
Triple-negative breast cancer (TNBC) is considered one of the un-manageable types of breast cancer, ...
Background and aimsThe tumor microenvironment (TME) has pivotal parts within multiple tumor models o...
This study presents a new way to investigate comprehensive trends in cancer nanotechnology research ...
This review is focused on opportunities for developing new approaches for filling the current void i...
Despite many technological breakthroughs, even the best breast cancer treatments available today are...
BackgroundLiver cancer (LC) is one of the most common malignancies. Currently, nanotechnology has ma...
Background: With rapid development in molecular biology techniques and a greater understanding of ca...
5noBreast cancer (BC) is the second leading cause of mortality in females after lung malignant neopl...
Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer tha...
A fundamental question in the field of technological forecasting and foresight is how to detect like...
The management of aggressive breast cancer, particularly, triple negative breast cancer (TNBC) remai...
Breast cancer is the second leading cause of cancer-related death of women in the United States, and...
Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has been foun...
BackgroundLiver cancer (LC) is one of the most common malignancies. Currently, nanotechnology has ma...
This study presents a new way to investigate comprehensive trends in cancer nanotechnology research ...
Triple-negative breast cancer (TNBC) is considered one of the un-manageable types of breast cancer, ...
Background and aimsThe tumor microenvironment (TME) has pivotal parts within multiple tumor models o...
This study presents a new way to investigate comprehensive trends in cancer nanotechnology research ...
This review is focused on opportunities for developing new approaches for filling the current void i...
Despite many technological breakthroughs, even the best breast cancer treatments available today are...
BackgroundLiver cancer (LC) is one of the most common malignancies. Currently, nanotechnology has ma...
Background: With rapid development in molecular biology techniques and a greater understanding of ca...
5noBreast cancer (BC) is the second leading cause of mortality in females after lung malignant neopl...
Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer tha...
A fundamental question in the field of technological forecasting and foresight is how to detect like...
The management of aggressive breast cancer, particularly, triple negative breast cancer (TNBC) remai...
Breast cancer is the second leading cause of cancer-related death of women in the United States, and...
Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has been foun...
BackgroundLiver cancer (LC) is one of the most common malignancies. Currently, nanotechnology has ma...